Provided by Tiger Trade Technology Pte. Ltd.

Henry Schein

72.22
-0.4600-0.63%
Volume:564.77K
Turnover:41.03M
Market Cap:8.28B
PE:22.09
High:73.36
Open:72.24
Low:71.78
Close:72.68
52wk High:89.29
52wk Low:60.56
Shares:114.70M
Float Shares:101.95M
Volume Ratio:0.53
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.27
EPS(LYR):3.27
ROE:8.70%
ROA:4.33%
PB:2.55
PE(LYR):22.09

Loading ...

Henry Schein Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Henry Schein Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 17

Insider Move at Henry Schein Sparks Fresh Buzz Among Investors

TIPRANKS
·
Mar 12

Henry Schein Director Kurt P. Kuehn Disposes of Common Shares

Reuters
·
Mar 12

Henry Schein Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 11

How Investors May Respond To Henry Schein (HSIC) Earnings, Buybacks And New AI-Enabled Dentrix Ascend Packages

Simply Wall St.
·
Mar 10

Henry Schein Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 07

Henry Schein Director Philip A. Laskawy Disposes of Common Shares

Reuters
·
Mar 07

Henry Schein Conference Appearances Spotlight Valuation Upside And Debt Risk

Simply Wall St.
·
Mar 05

Henry Schein Chairman Stanley M. Bergman Reports Disposal of Common Shares

Reuters
·
Mar 03

Henry Schein to Present at Leerink and Barclays Global Healthcare Conferences

Reuters
·
Mar 03

Henry Schein Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Mar 03

Henry Schein Inc. Files Initial Beneficial Ownership Statement for CEO and Director Frederick M. Lowery

Reuters
·
Mar 03

Analysts Have Conflicting Sentiments on These Healthcare Companies: Henry Schein (HSIC), Dyadic International (DYAI) and Bioventus (BVS)

TIPRANKS
·
Mar 02

Jefferies Adjusts Price Target on Henry Schein to $89 From $72, Maintains Hold Rating

MT Newswires Live
·
Mar 02

Will Strong Q4 2025 Results and Impairment Charge Reframe Henry Schein's (HSIC) Investment Narrative?

Simply Wall St.
·
Mar 02

Henry Schein Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 28

Henry Schein Chairman and CEO Stanley M. Bergman Disposes of Common Shares

Reuters
·
Feb 28

Henry Schein Inc. Releases Transcript of Fourth Quarter 2025 Earnings Call

Reuters
·
Feb 27

Biomerica Reports Real-World Data: Nearly 60% of Ibs Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction With the Infoods® Ibs Therapy

THOMSON REUTERS
·
Feb 26